🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 52 of 757 · Phase 3 first, then by program name

  1. Ertapenem

    Iterum Therapeutics plc

    Intra Abdominal Infections

    phase 3 small molecule completed

    1 trial

  2. EryDex Low dose DSP

    Quince Therapeutics

    Nervous System Disease

    phase 3 small molecule completed

    1 trial

  3. EryDex System

    Quince Therapeutics

    Ataxia Telangiectasia

    phase 3 other terminated

    1 trial

  4. Erythromycin

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 small molecule completed

    1 trial

  5. Erythropoiesis-Stimulating Agent (ESA)

    Akebia Europe Limited

    Anemia of Chronic Kidney Disease

    phase 3 small molecule active

    1 trial

  6. Erythropoietin

    First Tracks Biotherapeutics

    Premature Infants

    phase 3 small molecule active

    1 trial

  7. EscharEx, Placebo (Gel Vehicle), Amnion/Chorion Membrane Allograft

    MediWound Germany GmbH

    Venous leg ulcer

    phase 3 small molecule active

    1 trial

  8. Escitalopram

    Takeda Pharmaceuticals International AG

    Major Depressive Disorder

    phase 3 small molecule terminated

    1 trial

  9. Escitalopram

    China SXT Pharmaceuticals

    Mild-to-moderate Depression

    phase 3 small molecule completed

    1 trial

  10. Escitalopram

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 3 small molecule completed

    1 trial

  11. Esomeprazole Magnesium, NEXIUM 10 mg gastro-resistant granules for oral suspension, sachet, Esomeprazole Magnesium

    AstraZeneca AB

    Erosive Esophagitis

    phase 3 small molecule active

    1 trial

  12. Estradiol

    Teva Pharma GmbH

    Dyspareunia

    phase 3 small molecule completed

    1 trial

  13. Estradiol

    TherapeuticsMD

    Menopause

    phase 3 small molecule completed

    2 trials

  14. Estradiol

    TherapeuticsMD

    Vulvovaginal Atrophy

    phase 3 small molecule completed

    1 trial

  15. Estradiol Vaginal Tablets 10 mcg

    Amneal Pharma Europe Ltd

    Atrophic Vaginitis Due to Menopause

    phase 3 small molecule completed

    1 trial

  16. EstroTep 500 MBq/mL, solution injectable

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Women with ER+ HER2- metastatic breast cancer who progressed on first line therapy with CDK4/6 inhibitor and aromatase inhibitor

    phase 3 small molecule active

    1 trial

  17. Etanercept

    Coherus Oncology

    Plaque Psoriasis

    phase 3 small molecule completed

    1 trial

  18. Etanercept

    Coherus Oncology

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial

  19. Etanercept

    Sunshine Biopharma

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial

  20. Etavopivat A 100 mg, Etavopivat placebo., Etavopivat A 200 mg

    Novo Nordisk A/S

    sickle cell disease (SCD)

    phase 3 small molecule active

    1 trial

  21. Etavopivat A 200 mg

    Novo Nordisk A/S

    Sickle Cell Disease and Thalassaemia

    phase 3 small molecule active

    1 trial

  22. Eteplirsen

    Sarepta Therapeutics

    Muscular Dystrophy, Duchenne

    phase 3 small molecule active

    2 trials

  23. Etoposide

    First Tracks Biotherapeutics

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  24. Etoposide

    First Tracks Biotherapeutics

    Non-Hodgkin's Lymphoma

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources